50-µg mRNA-1273 Safe, Effective for Children Aged 6 to 11 Years
Estimated vaccine efficacy with two doses was 88.0 percent against COVID-19 at a time when delta was dominant circulating variant
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.